3124435

Source:http://linkedlifedata.com/resource/pubmed/id/3124435

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0007589, umls-concept:C0007634, umls-concept:C0023467, umls-concept:C0086418, umls-concept:C0302350, umls-concept:C1511938
pubmed:dateCreated	1988-3-8
pubmed:abstractText	Human myeloid leukemia cells have a growth advantage over normal cells because they do not differentiate into functional end-cells but remain in the proliferative pool. Several agents have been identified as inducers of differentiation of leukemia cells; among them are the retinoids, 1 alpha,25-dihydroxyvitamin D3 and human tumor necrosis factor alpha, which will be discussed in the following chapter.
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/CA 26038, http://linkedlifedata.com/resource/pubmed/grant/CA 32737, http://linkedlifedata.com/resource/pubmed/grant/CA 33936
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0141053
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Calcitriol, http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Retinoids, http://linkedlifedata.com/resource/pubmed/chemical/Tretinoin, http://linkedlifedata.com/resource/pubmed/chemical/Tumor Necrosis Factor-alpha
pubmed:status	MEDLINE
pubmed:issn	0001-5792
pubmed:author	pubmed-author:KoefflerH PHP, pubmed-author:ToblerAA
pubmed:issnType	Print
pubmed:volume	78 Suppl 1
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	127-35
pubmed:dateRevised	2007-11-15
pubmed:meshHeading	pubmed-meshheading:3124435-Adolescent, pubmed-meshheading:3124435-Adult, pubmed-meshheading:3124435-Aged, pubmed-meshheading:3124435-Aged, 80 and over, pubmed-meshheading:3124435-Animals, pubmed-meshheading:3124435-Calcitriol, pubmed-meshheading:3124435-Cell Differentiation, pubmed-meshheading:3124435-Clinical Trials as Topic, pubmed-meshheading:3124435-Humans, pubmed-meshheading:3124435-Leukemia, Experimental, pubmed-meshheading:3124435-Leukemia, Myeloid, Acute, pubmed-meshheading:3124435-Mice, pubmed-meshheading:3124435-Middle Aged, pubmed-meshheading:3124435-Myelodysplastic Syndromes, pubmed-meshheading:3124435-Recombinant Proteins, pubmed-meshheading:3124435-Retinoids, pubmed-meshheading:3124435-Tretinoin, pubmed-meshheading:3124435-Tumor Cells, Cultured, pubmed-meshheading:3124435-Tumor Necrosis Factor-alpha
pubmed:year	1987
pubmed:articleTitle	Differentiation of human acute myelogenous leukemia cells: therapeutic possibilities.
pubmed:affiliation	UCLA School of Medicine.
pubmed:publicationType	Journal Article, Clinical Trial, Research Support, U.S. Gov't, P.H.S., Review, Research Support, Non-U.S. Gov't